Everyone is eager for vaccine news and numbers, but longtime investor Tony Waskiewicz argues the real portfolio boosters will be any actions from the Fed and Congress.
Muted market gains this month, strategists say, are overshadowed by blow-out earlier months.
An LPL historical study shows the tricky dynamics for stocks in the year’s final two months.
S&P 500 profits should be down just 7.1%, a big upgrade from more dire previous calls.
The markets see stability ahead, despite a delayed election result, Senate runoff races, and voter fraud claims from the president.
Not really, says UBS’s Haefele, sounding optimistic on vaccines and possible fresh aid in 2021.
So say two savants from Principal Financial, at CIO’s Summit.
Coronavirus - COVID-19
The election and the virus could trigger another stock slump, says strategist Christopher Harvey.
An array of forces will juice stocks anew and the early-September drop is just a correction, the firm argues.
A quarter of the S&P 500’s rise since May is linked to positive developments on a virus inoculation, UBS says.
A bouncing-back S&P 500 tends to drop by 5%, two-plus months after setting a new record, says CFRA’s Sam Stovall. Would this impact the presidential race?
The economy and the stock market should be able to overcome the virus, say the firm’s strategists.
One relates to the pandemic, one to politics, and one to federal stimulus.